Skip to main content
Autobound logo
Amgen10-Q: Market share loss

XGEVA sales fall 27% YoY as biosimilar competition intensifies after patent expiry

Read at SEC EDGAR

What happened

Global sales for XGEVA decreased by $155M in Q1 2026 compared to prior year, driven by a 19% volume decline. The company anticipates accelerated sales erosion throughout 2026 due to biosimilar launches.

Source

SEC EDGARApr 30, 2026

Quarterly report (Form 10-Q)

Amgen 10-Q

Filing excerpt

The decrease in global XGEVA sales for the three months ended March 31, 2026 was driven by lower volume of 19% and lower net selling price.

sec.gov/Archives/edgar/data/318154/000031815426000057/amgn-20260331.htmRead the full source

Other signals in this filing (11)

Extracted by Autobound

From the Signal API record
Signal
10-Q: Market share loss

What this signalsFilings often name leadership changes, deals and spending plans.

Fiscal year end
03/31
Filed
Apr 30, 2026

More from Amgen

Company page →

More 10-Q signals at other companies

The full record

From the Signal API record

Numbers

Dollar figure
-$155M (Decline in Total XGEVA sales vs prior year quarter ($566M to $411M))
Percent
-27% (Total XGEVA sales change YoY)

Details

CIK
318154
Accession number
0000318154-26-000057
Timeframe
Current quarter
Filing year
2026
Fiscal year
0
Why it matters
Urgency to improve

Topics and mentions

Regions named

  • U.S.
  • ROW
  • Europe

Extraction

Confidence
High
Relevance
90%
Sentiment
Negative
Detected
May 5, 2026
signal_type
sec-10q
signal_subtype
marketShareLoss

Use this data

Get every 10-Q signal for Amgen and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Amgen this week?”

    MCP setup guide

  2. Send it to your own tools

    The Signal API returns 10-Q signals for any list of companies as JSON, for your CRM, warehouse or app.

    Signal API

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full sec-10q record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Start Free1,000 free creditsUse it in Claude via MCP
Show the full JSONThe record on this page and the API request

GET /v1/signals/3302ac93-17c8-42e3-bed1-cd3b98b23226 returns this record as JSON. POST /v1/companies/enrich returns every signal for amgen.com.

{
  "signal_id": "3302ac93-17c8-42e3-bed1-cd3b98b23226",
  "signal_type": "sec-10q",
  "signal_subtype": "marketShareLoss",
  "detected_at": "2026-05-05T08:48:22.11+00:00",
  "company": {
    "name": "Amgen",
    "domain": "amgen.com"
  },
  "data": {
    "detail": "Global sales for XGEVA decreased by $155M in Q1 2026 compared to prior year, driven by a 19% volume decline. The company anticipates accelerated sales erosion throughout 2026 due to biosimilar launches.",
    "metrics": {
      "pct": -27,
      "timeframe": "current_quarter",
      "pct_context": "Total XGEVA sales change YoY",
      "dollar_context": "Decline in Total XGEVA sales vs prior year quarter ($566M to $411M)",
      "dollar_millions": -155
    },
    "summary": "XGEVA sales fall 27% YoY as biosimilar competition intensifies after patent expiry",
    "excerpts": "The decrease in global XGEVA sales for the three months ended March 31, 2026 was driven by lower volume of 19% and lower net selling price.",
    "relevance": 0.9,
    "sentiment": "negative",
    "confidence": "high",
    "source_url": "https://www.sec.gov/Archives/edgar/data/318154/000031815426000057/amgn-20260331.htm",
    "filing_date": "2026-04-30",
    "filing_year": 2026,
    "fiscal_year": 0,
    "fiscal_year_end": "03/31",
    "sales_relevance": "Urgency to improve",
    "signal_category": "market",
    "regions_mentioned": [
      "U.S.",
      "ROW",
      "Europe"
    ]
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.